Apotex Corp., a Toronto-based maker of generic pharmaceutical drugs, announced Wednesday it will expand with a new $184 million research center and manufacturing plant in Miramar, which will also be its U.S. headquarters.
The Canadian manufacturer already has about 230 employees in Miramar and nearly 90 in Weston. The company said it plans at least 150 new jobs in Miramar.
"We can leverage on that existing infrastructure," said Jeremy Desai, CEO and president of Apotex. He said the c
RelSci News & Alerts gets you: